2022 annual financial data
Contineum Therapeutics 2022 Operating margin
Contineum Therapeutics 2022 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -22,720,000 USD and net income was -24,253,000 USD.
Operating cash flow was -20,121,000 USD.
Get free Contineum Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -22,720,000 USD
- Net income
- -24,253,000 USD
- Operating cash flow
- -20,121,000 USD